Editas Medicine, Inc.
MODIFIED NATURAL KILLER (NK) CELLS FOR IMMUNOTHERAPY

Abstract:

The present disclosure is directed to the generation of NK cells (or other lymphocytes) from induced pluripotent cells that have been derived from cells, e.g., developmentally mature T cells, and uses thereof for immunotherapy.